Literature DB >> 24723721

Genome Sequence of Bacterial Interference Strain Staphylococcus aureus 502A.

Dane Parker1, Apurva Narechania, Robert Sebra, Gintaras Deikus, Samuel Larussa, Chanelle Ryan, Hannah Smith, Alice Prince, Barun Mathema, Adam J Ratner, Barry Kreiswirth, Paul J Planet.   

Abstract

Staphylococcus aureus 502A was a strain used in bacterial interference programs during the 1960s and early 1970s. Infants were deliberately colonized with 502A with the goal of preventing colonization with more invasive strains. We present the completed genome sequence of this organism.

Entities:  

Year:  2014        PMID: 24723721      PMCID: PMC3983310          DOI: 10.1128/genomeA.00284-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Staphylococcus aureus 502A was initially isolated in 1963 from a nurse in a newborn nursery who was caring for a cluster of 40 neonates who also became colonized with this strain (1). Colonization with 502A appeared to prevent infection with the exfoliative toxin-producing strain 80/81 that was epidemic in hospitals during the early 1960s (1–4). Thousands of neonates were inoculated with 502A in their nares and on their umbilical stumps, and the strain often persisted for months, only rarely causing disease itself (3, 5, 6). Strain 502A was also effective in protecting adults from virulent isolates of S. aureus (2, 7). However, the practice was abandoned after several infections and a death were attributed to the 502A strain (5). We recently showed that the innate immune response to 502A is markedly different from the response to the current epidemic USA300 strain, but our initial genomic analysis did not find any striking differences in the repertoire of virulence determinants (8). S. aureus DNA was isolated after lysostaphin treatment (6 µg/ml, 1 h, 37°C) using standard procedures. We used 3.5 µg of DNA to construct SMRTbell libraries for the PacBio (Pacific Bioscience) sequencing platform using polymerase enzyme-DNA bound complexes with an average insert size of ~20 kb, as assessed by the Agilent 12000 bioanalyzer gel chip following size selection using the Sage BluePippin 0.75% agarose cassette from 7,000 to 50,000 bp. The binding chemistry was done using the PacBio P5-C3 DNA/polymerase binding kit. A DNA/polymerase complex of the sample was prepared using 0.5 nM of the SMRTbell library and 10× excess DNA polymerase. All 20-kb samples were magbead loaded prior to immobilization at 75 pM for 30 min on SMRTcells, ensuring Poisson-like loading distribution. Sequencing was done on a PacBio-RSII sequencer using 180-min continuous collection times and C3 sequencing chemistry, allowing collection of subreads of ~36,000 bp. We obtained 236× coverage, with 145,600 mapped reads with a mean read length of 6,401 bp (N50, 8,802 bp). Assembly of reads was done with the HGAP2 v 2.1 de novo assembly pipeline, generating five contigs. Manual assembly resolved to 2 contigs, a circular chromosome (2,776,796 bp) and a plasmid (22,900 bp). The plasmid, designated SAP060A, had been sequenced previously (GQ900416.1) and has genes for putative enterotoxins and cadmium resistance. Comparison with a 502A Ion Torrent-generated genomic sequence (8) revealed only one high-quality (q > 20) base-pair difference, suggesting high accuracy. However, there were 888 insertions/deletions identified between sequences. This discrepancy may be due to known homopolymer-related problems in Ion Torrent- and PacBio-generated sequences. Colonization is a prerequisite for invasive disease, making the factors of this initial step in infection excellent targets for prevention. The complete genome sequence of 502A may help develop strategies that favor colonization with relatively benign strains over more virulent organisms or selectively target virulent organisms for decolonization.

Nucleotide sequence accession numbers.

This genome sequence has been deposited in GenBank under the accession numbers CP007454 and CP007455.
  8 in total

1.  CONTROL OF A STAPHYLOCOCCAL OUTBREAK IN A NURSERY, USE OF BACTERIAL INTERFERENCE.

Authors:  I J LIGHT; J M SUTHERLAND; J E SCHOTT
Journal:  JAMA       Date:  1965-08-30       Impact factor: 56.272

2.  Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. V. An analysis and interpretation.

Authors:  H R SHINEFIELD; J C RIBBLE; H F EICHENWALD; M BORIS; J M SUTHERLAND
Journal:  Am J Dis Child       Date:  1963-06

3.  Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. I. Preliminary observations on artificial colonzation of newborns.

Authors:  H R SHINEFIELD; J C RIBBLE; M BORIS; H F EICHENWALD
Journal:  Am J Dis Child       Date:  1963-06

4.  Bacterial interference among strains of Staphylococcus aureus in man.

Authors:  R Aly; H I Maibach; H R Shinefield; A Mandel; W G Strauss
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Fatal septicemia due to Staphylococcus aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs.

Authors:  P W Houck; J D Nelson; J L Kay
Journal:  Am J Dis Child       Date:  1972-01

6.  Bacterial interference in the therapy of recurrent staphylococcal infections. Multiple abscesses due to the implantation of the 502A strain of staphylococcus.

Authors:  D J Drutz; M H Van Way; W Schaffner; M G Koenig
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

7.  Bacterial interference: protection against staphylococcal disease.

Authors:  M Boris
Journal:  Bull N Y Acad Med       Date:  1968-10

8.  Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains.

Authors:  Dane Parker; Paul J Planet; Grace Soong; Apurva Narechania; Alice Prince
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

  8 in total
  18 in total

1.  Using Quantitative Spectrometry to Understand the Influence of Genetics and Nutritional Perturbations On the Virulence Potential of Staphylococcus aureus.

Authors:  Jessica R Chapman; Divya Balasubramanian; Kayan Tam; Manor Askenazi; Richard Copin; Bo Shopsin; Victor J Torres; Beatrix M Ueberheide
Journal:  Mol Cell Proteomics       Date:  2017-02-14       Impact factor: 5.911

2.  Resistance to Acute Macrophage Killing Promotes Airway Fitness of Prevalent Community-Acquired Staphylococcus aureus Strains.

Authors:  Vijaya Kumar Yajjala; Vinai Chittezham Thomas; Christopher Bauer; Tyler D Scherr; Karl J Fischer; Paul D Fey; Kenneth W Bayles; Tammy Kielian; Keer Sun
Journal:  J Immunol       Date:  2016-04-06       Impact factor: 5.422

3.  Revisiting Bacterial Interference in the Age of Methicillin-resistant Staphylococcus aureus: Insights Into Staphylococcus aureus Carriage, Pathogenicity and Potential Control.

Authors:  Paul J Planet; Dane Parker; Naomi L Ruff; Henry R Shinefield
Journal:  Pediatr Infect Dis J       Date:  2019-09       Impact factor: 2.129

4.  Therapeutic Inhibition of Staphylococcus aureus ArlRS Two-Component Regulatory System Blocks Virulence.

Authors:  Jakub M Kwiecinski; Diamond A Jelani; Ernesto J Fuentes; Alexander R Horswill
Journal:  Antimicrob Agents Chemother       Date:  2022-06-23       Impact factor: 5.938

5.  Responses to chemical cross-talk between the Mycobacterium ulcerans toxin, mycolactone, and Staphylococcus aureus.

Authors:  Laxmi Dhungel; Lindsey Burcham; Joo Youn Park; Harshini Devi Sampathkumar; Albert Cudjoe; Keun Seok Seo; Heather Jordan
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  Scaffolding of a bacterial genome using MinION nanopore sequencing.

Authors:  E Karlsson; A Lärkeryd; A Sjödin; M Forsman; P Stenberg
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

7.  Single-molecule sequencing reveals the molecular basis of multidrug-resistance in ST772 methicillin-resistant Staphylococcus aureus.

Authors:  Eike J Steinig; Patiyan Andersson; Simon R Harris; Derek S Sarovich; Anand Manoharan; Paul Coupland; Matthew T G Holden; Julian Parkhill; Stephen D Bentley; D Ashley Robinson; Steven Y C Tong
Journal:  BMC Genomics       Date:  2015-05-16       Impact factor: 3.969

8.  Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance.

Authors:  Cassandra L Quave; James T Lyles; Jeffery S Kavanaugh; Kate Nelson; Corey P Parlet; Heidi A Crosby; Kristopher P Heilmann; Alexander R Horswill
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 9.  Flipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence.

Authors:  Cassandra L Quave; Alexander R Horswill
Journal:  Front Microbiol       Date:  2014-12-12       Impact factor: 5.640

10.  Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements.

Authors:  Sarah L Baines; Benjamin P Howden; Helen Heffernan; Timothy P Stinear; Glen P Carter; Torsten Seemann; Jason C Kwong; Stephen R Ritchie; Deborah A Williamson
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.